Replies to post #5837 on Talon Therapeutics Inc (fka TLON)

[10bags]

Kurt A. Gustafson - Chief Financial Officer, Principal Accounting Officer and Executive Vice President

Sure. So specifically for the CVR, there's a number of onetime milestones, and I can run through those with you here just to go through some of the details. The first one is hit -- there's a $5 million milestone. It's hit after net sales hit $30 million. And then there's a $10 million milestone at $60 million in sales, $25 million at $100 million and then $50 million at a $200 million sales point and $100 million milestone when sales hit $400 million in a calendar year. And then there's one additional milestone. That's $5 million upon the approval of Menadione. So I think that outlines the full amount under the CVR.

[BioRecruiter]

hold, i figured with the CVR's I could get some money back. The first few payments should be easy but the last 2 not sure. I know the 400M in sales has to be done in a calendar year which is just nuts, and I'm not sure about the 200M in sales. If the 200M in sales is just in addition then I may get back most of my money. I just emailed SD and asked if he was awake when he made this deal. It's amazing becuase I'm not sure if the CEO or anyone at Talon made money. I mean who would agree to this deal? All the employees at Talon had options, there worthless, and even if you had stock, its worthless, and the change of control money where the CEO and CFO got a %, well they didnt get anything. Who actually made money? WP and DF gave Talon 100M, they got 27M in stock and 11M payment, and maybe 198M if we reach certain goals. Who in their right mind would agree to this. They could have made more money getting a partner and selling it on their own